Citigroup’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,554,433
| Closed | -$590K | – | 7842 |
|
|
2017
Q3 | $560K | Hold |
1,554,433
| – | – | ﹤0.01% | 4003 |
|
|
2017
Q2 | $591K | Hold |
1,554,433
| – | – | ﹤0.01% | 3836 |
|
|
2017
Q1 | $699K | Hold |
1,554,433
| – | – | ﹤0.01% | 3576 |
|
|
2016
Q4 | $591K | Hold |
1,554,433
| – | – | ﹤0.01% | 4208 |
|
|
2016
Q3 | $415K | Hold |
1,554,433
| – | – | ﹤0.01% | 4066 |
|
|
2016
Q2 | $373K | Sell |
1,554,433
-200
| -0% | -$34 | ﹤0.01% | 3942 |
|
|
2016
Q1 | $177K | Sell |
1,554,633
-270
| -0% | -$29 | ﹤0.01% | 5206 |
|
|
2015
Q4 | $175K | Buy |
1,554,903
+2,211
| +0.1% | +$312 | ﹤0.01% | 4873 |
|
|
2015
Q3 | $295K | Buy |
1,552,692
+7
| +0% | +$2 | ﹤0.01% | 4206 |
|
|
2015
Q2 | $1.09M | Sell |
1,552,685
-61
| -0% | -$42 | ﹤0.01% | 3096 |
|
|
2015
Q1 | $1.05M | Hold |
1,552,746
| – | – | ﹤0.01% | 3043 |
|
|
2014
Q4 | $1.23M | Sell |
1,552,746
-100
| -0% | -$68 | ﹤0.01% | 2930 |
|
|
2014
Q3 | $722K | Sell |
1,552,846
-139
| -0% | -$67 | ﹤0.01% | 3251 |
|
|
2014
Q2 | $776K | Hold |
1,552,985
| – | – | ﹤0.01% | 3163 |
|
|
2014
Q1 | $481K | Buy |
1,552,985
+999,970
| +181% | +$372K | ﹤0.01% | 3508 |
|
|
2013
Q4 | $188K | Buy |
553,015
+550,000
| +18,242% | +$665K | ﹤0.01% | 4718 |
|
|
2013
Q3 | $6K | Hold |
3,015
| – | – | ﹤0.01% | 6392 |
|
|
2013
Q2 | $5K | Buy |
+3,015
| New | +$5.3K | ﹤0.01% | 6366 |
|
Citigroup's GCVRZ Position: Q4 2017 in Review
Citigroup sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 1,554,433 shares — an estimated $590K sold.
Citigroup first reported a position in GCVRZ in Q2 2013 and held it in 18 quarters. The position peaked at $1.23M in Q4 2014. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.
- Citigroup reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
- Citigroup sold 1,554,433 Sanofi Contingent Value Rights shares in Q4 2017, an estimated $590K.
- Citigroup first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 18 quarters.
- Citigroup's Sanofi Contingent Value Rights position peaked at $1.23M in Q4 2014.
- 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.